Ads
related to: mitraclip mri compatible tests for prostate cancer- Talk To Your Doctor
Review questions to start a
conversation with your doctor.
- Patient Resources
Download informative brochures for
patients and caregivers.
- Reimbursement Support
The patient support program
can assist insurance assessment.
- Find An Imaging Site
Locate the nearest imaging site
or contact customer service.
- Talk To Your Doctor
Search results
Results from the WOW.Com Content Network
To try and overcome current capacity issues with MRIs for prostate cancer, they have now set up the PRIME trial to explore whether a shorter and cheaper MRI scan could become the new standard of care.
MitraClip (mitral clip) is a medical device used to treat mitral valve regurgitation for individuals who should not have open-heart surgery. It is implanted via a tri-axial transcatheter technique and involves suturing together the anterior and posterior mitral valve leaflets.
In a 2015 articles in the Journal of Urology, Thompson reported multi-parametric MRI detection of significant prostate cancer had sensitivity of 96%, specificity of 36%, negative predictive value and positive predictive values of 92% and 52%; when PI-RADS was incorporated into a multivariate analysis (PSA, digital rectal exam, prostate volume ...
The technique has demonstrated higher accuracy than other modalities in assessing seminal vesicle invasion and extra-capsular extension (ECE) of prostate cancer (96% and 81% respectively). Endorectal coil MRI is useful for determining the extent of spread and local invasion of cancers of the prostate, rectum, and anus. [2]
By temporarily altering the anatomy these products have the potential to allow for improved cancer targeting while minimizing risk to neighboring healthy tissues. Prostate rectum spacers should be compatible with all prostate cancer radiotherapy treatments including 3D conformal, IMRT and stereotactic radiation and brachytherapy. [citation needed]
Prostate cancer antigen 3 is a urine test that detects the overexpression of the PCA3 gene, an indicator of prostate cancer. [32] [46] [47] [44] ConfirmMDx is performed on tissue taken during a prostate biopsy. The test identifies men with clinically significant prostate cancer who would benefit from further testing and treatment.
Ads
related to: mitraclip mri compatible tests for prostate cancer